The proteomic approach to investigate Parkinson's desease: pathogenetic mechanisms and biomarkers discovery.

作者: Tiziana Alberio

DOI:

关键词:

摘要: 4 1.INTRODUCTION 6 1.1 The proteomic approach to investigate pathogenethic mechanisms and find biomarkers for Parkinson‟s disease 7 1.2 8 1.2.1. Epidemiology Genetics 11 1.3 Alteration of dopamine homeostasis oxidative stress 13 1.4 α-Synuclein 14 1.5 DJ-1 19 1.6 Cellular models α-synuclein toxicity 20 1.7 as a mitochondrial 22 1.8 Biomarkers 27 1.8.1 Rationale peripheral PD 29 1.8.2 Potential source PD: Peripheral blood lymphocytes 30 2.AIM OF THE PROJECT 34 3.MATERIALS AND METHODS 36 3.1 A SH-SY5Y MODEL TO INVESTIGATE PATHOGENETIC MECHANISMS ......... 37 3.1.1 Cell cultures transfection 3.1.2 viability 3.1.3 2-DE electrophoresis statistical analysis 38 3.1.4 LC-MS-MS protein identification 39 3.1.5 Bioinformatics enrichment network clustering 40 3.1.6 Apoptosis 3.1.7 Transient luciferase gene reporter assay 41 3.1.8 Western blotting α-synuclein, HSP70 14-3-3 3.1.9 cycle 42 3.1.10 Voltage Dependent Anion Channels (VDACs) 43 MONODIMENSIONAL WESTERN BLOTTING (TIME COURSE) VDAC2 TWO-DIMENSIONAL 44 3.1.11 Tetramethylrhodamine methyl ester (TMRM) staining 3.1.12 Measurement Ca2+ flux mitochondria using Aequorin 45 CELL PREPARATION, CALCIUM-PHOSPHATE TRANSFECTION PROCEDURE RECONSTITUTION FUNCTIONAL AEQUORIN

参考文章(251)
K. A. Jellinger, Post mortem studies in Parkinson’s disease — is it possible to detect brain areas for specific symptoms? Journal of Neural Transmission-supplement. ,vol. 56, pp. 1- 29 ,(1999) , 10.1007/978-3-7091-6360-3_1
Fiona Thomson, Parkinson's Disease Neuron. ,vol. 39, pp. 889- 909 ,(2003) , 10.1016/S0896-6273(03)00568-3
Marc C. Meulener, Charles L. Graves, Deepak M. Sampathu, Cecilia E. Armstrong-Gold, Nancy M. Bonini, Benoit I. Giasson, DJ-1 is present in a large molecular complex in human brain tissue and interacts with α-synuclein Journal of Neurochemistry. ,vol. 93, pp. 1524- 1532 ,(2005) , 10.1111/J.1471-4159.2005.03145.X
F BLANDINI, A MANGIAGALLI, M COSENTINO, F MARINO, A SAMUELE, E RASINI, R FANCELLU, E MARTIGNONI, G RIBOLDAZZI, D CALANDRELLA, G M. FRIGO, G NAPPI, Peripheral markers of apoptosis in Parkinson's disease: the effect of dopaminergic drugs. Annals of the New York Academy of Sciences. ,vol. 1010, pp. 675- 678 ,(2003) , 10.1196/ANNALS.1299.123
Shankar J. Chinta, Julie K. Andersen, Redox imbalance in Parkinson's disease. Biochimica et Biophysica Acta. ,vol. 1780, pp. 1362- 1367 ,(2008) , 10.1016/J.BBAGEN.2008.02.005
C. Savio Chan, Jaime N. Guzman, Ema Ilijic, Jeff N. Mercer, Caroline Rick, Tatiana Tkatch, Gloria E. Meredith, D. James Surmeier, ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease Nature. ,vol. 447, pp. 1081- 1086 ,(2007) , 10.1038/NATURE05865
Tiziana Alberio, Alessandra Maria Bossi, Alberto Milli, Elisa Parma, Marzia Bruna Gariboldi, Giovanna Tosi, Leonardo Lopiano, Mauro Fasano, None, Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. FEBS Journal. ,vol. 277, pp. 4909- 4919 ,(2010) , 10.1111/J.1742-4658.2010.07896.X
Maria Grazia Spillantini, Marie Luise Schmidt, Virginia M.-Y. Lee, John Q. Trojanowski, Ross Jakes, Michel Goedert, α-Synuclein in Lewy bodies Nature. ,vol. 388, pp. 839- 840 ,(1997) , 10.1038/42166